Canine-Assisted Profiling of Lung Cancer From Human Breath

Lung Cancer Clinical Trial

Official title:

Canine-Assisted Profiling of Lung Cancer From Human Breath

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02759679
• Other study ID #: REK_2013/2053
• Status: Terminated
• Phase: N/A
• Start date: May 2016
• Est. completion date: December 2019

Study information

• Verified date: February 2024
• Source: Haukeland University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study aims to optimize and define a reproducible and non-invasive method for canine assisted lung cancer detection, using human breath samples from patients and controls for training and testing purposes.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 650
• Est. completion date: December 2019
• Est. primary completion date: December 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion criteria:

Healthy volunteers, lung cancer or other lung disease.

Exclusion criteria:

Other known malignancy.

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Intervention

Other:
• Human breath samples

Locations

Country	Name	City	State
Norway	Haukeland University Hospital	Bergen

Sponsors (1)

Lead Sponsor	Collaborator
Haukeland University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensitivity and specificity for lung cancer, of canines sniffing breath samples	Patients and Controls deliver breath samples to be presented for dogs in a Remote facility. Outcomes will be reported for individual dogs and combinations of dogs.	2 years